These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
254 related articles for article (PubMed ID: 21277328)
1. Activated T cells induce rapid CD83 expression on B cells by engagement of CD40. Kretschmer B; Kühl S; Fleischer B; Breloer M Immunol Lett; 2011 May; 136(2):221-7. PubMed ID: 21277328 [TBL] [Abstract][Full Text] [Related]
2. Engagement of CD83 on B cells modulates B cell function in vivo. Kretschmer B; Lüthje K; Schneider S; Fleischer B; Breloer M J Immunol; 2009 Mar; 182(5):2827-34. PubMed ID: 19234177 [TBL] [Abstract][Full Text] [Related]
3. Activated T hybridomas induce upregulation of B7-1 on bystander B lymphoma cells by a contact-dependent interaction utilizing CD40 ligand. Jones KW; Hackett CJ Cell Immunol; 1996 Nov; 174(1):42-53. PubMed ID: 8929453 [TBL] [Abstract][Full Text] [Related]
4. CD83 is a regulator of murine B cell function in vivo. Breloer M; Kretschmer B; Lüthje K; Ehrlich S; Ritter U; Bickert T; Steeg C; Fillatreau S; Hoehlig K; Lampropoulou V; Fleischer B Eur J Immunol; 2007 Mar; 37(3):634-48. PubMed ID: 17266176 [TBL] [Abstract][Full Text] [Related]
5. CD83 on murine APC does not function as a costimulatory receptor for T cells. Kretschmer B; Lüthje K; Ehrlich S; Osterloh A; Piedavent M; Fleischer B; Breloer M Immunol Lett; 2008 Oct; 120(1-2):87-95. PubMed ID: 18675848 [TBL] [Abstract][Full Text] [Related]
6. CD83 influences cell-surface MHC class II expression on B cells and other antigen-presenting cells. Kuwano Y; Prazma CM; Yazawa N; Watanabe R; Ishiura N; Kumanogoh A; Okochi H; Tamaki K; Fujimoto M; Tedder TF Int Immunol; 2007 Aug; 19(8):977-92. PubMed ID: 17804692 [TBL] [Abstract][Full Text] [Related]
7. CD83 modulates B cell function in vitro: increased IL-10 and reduced Ig secretion by CD83Tg B cells. Kretschmer B; Lüthje K; Guse AH; Ehrlich S; Koch-Nolte F; Haag F; Fleischer B; Breloer M PLoS One; 2007 Aug; 2(8):e755. PubMed ID: 17710154 [TBL] [Abstract][Full Text] [Related]
8. CD83 regulates splenic B cell maturation and peripheral B cell homeostasis. Lüthje K; Kretschmer B; Fleischer B; Breloer M Int Immunol; 2008 Aug; 20(8):949-60. PubMed ID: 18544574 [TBL] [Abstract][Full Text] [Related]
9. CD83 regulates lymphocyte maturation, activation and homeostasis. Breloer M; Fleischer B Trends Immunol; 2008 Apr; 29(4):186-94. PubMed ID: 18329338 [TBL] [Abstract][Full Text] [Related]
10. Molecular interactions mediating T-B lymphocyte collaboration in human lymphoid follicles. Roles of T cell-B-cell-activating molecule (5c8 antigen) and CD40 in contact-dependent help. Lederman S; Yellin MJ; Inghirami G; Lee JJ; Knowles DM; Chess L J Immunol; 1992 Dec; 149(12):3817-26. PubMed ID: 1281189 [TBL] [Abstract][Full Text] [Related]
11. Co-stimulation by anti-immunoglobulin is required for B cell activation by CD40Llow T cells. Poudrier J; Owens T Eur J Immunol; 1994 Dec; 24(12):2993-9. PubMed ID: 7805727 [TBL] [Abstract][Full Text] [Related]
12. Transgenic expression of a CD83-immunoglobulin fusion protein impairs the development of immune-competent CD4-positive T cells. Lüthje K; Cramer SO; Ehrlich S; Veit A; Steeg C; Fleischer B; Bonin Av; Breloer M Eur J Immunol; 2006 Aug; 36(8):2035-45. PubMed ID: 16841299 [TBL] [Abstract][Full Text] [Related]
13. The regulation of T cell-dependent antibody formation in vitro by CD40 ligand and IL-2. Grabstein KH; Maliszewski CR; Shanebeck K; Sato TA; Spriggs MK; Fanslow WC; Armitage RJ J Immunol; 1993 Apr; 150(8 Pt 1):3141-7. PubMed ID: 7682232 [TBL] [Abstract][Full Text] [Related]
14. CD83: a regulatory molecule of the immune system with great potential for therapeutic application. Fujimoto Y; Tedder TF J Med Dent Sci; 2006 Jun; 53(2):85-91. PubMed ID: 16913569 [TBL] [Abstract][Full Text] [Related]
15. CD40 molecules induce down-modulation and endocytosis of T cell surface T cell-B cell activating molecule/CD40-L. Potential role in regulating helper effector function. Yellin MJ; Sippel K; Inghirami G; Covey LR; Lee JJ; Sinning J; Clark EA; Chess L; Lederman S J Immunol; 1994 Jan; 152(2):598-608. PubMed ID: 7506727 [TBL] [Abstract][Full Text] [Related]
16. CD40 ligand induction on T cell subsets by peptide-presenting B cells: implications for development of the primary T and B cell response. Jaiswal AI; Croft M J Immunol; 1997 Sep; 159(5):2282-91. PubMed ID: 9278317 [TBL] [Abstract][Full Text] [Related]
17. Helper effector function of human T cells stimulated by anti-CD3 mAb can be enhanced by co-stimulatory signals and is partially dependent on CD40-CD40 ligand interaction. Kwekkeboom J; de Rijk D; Kasran A; Barcy S; de Groot C; de Boer M Eur J Immunol; 1994 Mar; 24(3):508-17. PubMed ID: 7510232 [TBL] [Abstract][Full Text] [Related]
18. Cognate T cell help for CD40-deficient B cells induces c-myc RNA expression, but DNA synthesis requires an additional signal through surface Ig. Schrader CE; Stavnezer J; Kikutani H; Parker DC J Immunol; 1997 Jan; 158(1):153-62. PubMed ID: 8977186 [TBL] [Abstract][Full Text] [Related]
19. Signaling via major histocompatibility complex class II molecules and antigen receptors enhances the B cell response to gp39/CD40 ligand. Bishop GA; Warren WD; Berton MT Eur J Immunol; 1995 May; 25(5):1230-8. PubMed ID: 7539751 [TBL] [Abstract][Full Text] [Related]
20. The effects of IFN-gamma on CD40-mediated activation of B cells from X-linked immunodeficient or normal mice. Johnson-Léger C; Hasbold J; Holman M; Klaus GG J Immunol; 1997 Aug; 159(3):1150-9. PubMed ID: 9233608 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]